Ticker: ALGS

Company Overview: Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a clinical-stage biotechnology company focused on developing innovative therapeutics for viral diseases and liver diseases, including treatments for chronic hepatitis B virus (HBV) infection and metabolic dysfunction-associated steatoh...